NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Reviewed May 26, 2026

Rabeprazole

Prescription ·Strong evidence ·Reviewed May 2026

Rabeprazole is a proton pump inhibitor used for gastroesophageal reflux disease, erosive esophagitis, Helicobacter pylori combination therapy, duodenal ulcer, and pathologic hypersecretory conditions. Long-term or high-dose use can contribute to hypomagnesemia, vitamin B12 deficiency, reduced non-heme iron absorption, fracture risk, kidney injury, and enteric infection risk.

What it's good for
  • Healing and maintenance of erosive esophagitis4
  • Symptom control in GERD3,4
  • Part of combination therapy for Helicobacter pylori eradication4
  • Treatment of duodenal ulcer4
  • Management of Zollinger-Ellison syndrome and other hypersecretory states
What to watch for
  • Headache
  • Diarrhea
  • Nausea
  • Known hypersensitivity to rabeprazole, substituted benzimidazoles, or formulation components4
  • Do not use with rilpivirine-containing products due to reduced antiviral exposure4

The bottom line

Evidence rating strong. Most-documented uses: healing and maintenance of erosive esophagitis, symptom control in gerd, part of combination therapy for helicobacter pylori eradication. 4 sources indexed (2007–2026), with 5 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Rabeprazole is an acid-activated benzimidazole prodrug that concentrates in gastric parietal cell canaliculi. After protonation it covalently inhibits the hydrogen-potassium ATPase proton pump, suppressing basal and stimulated gastric acid secretion until new pumps are synthesized. Reduced acidity supports mucosal healing but can impair release and absorption of acid-dependent nutrients and drugs.2,3

Class
Proton pump inhibitor
Absorption
Best on an empty stomach
Dosing

Dosing & protocol.

Common range
Adults: commonly 20 mg once daily for GERD or erosive esophagitis; 20 mg twice daily as part of H. pylori regimens; higher individualized doses may be used for hypersecretory conditions.
Recommended form
Delayed-release oral tablet or sprinkle capsule, swallowed according to product instructions

Delayed-release tablets are usually taken once daily, often before a meal depending on indication. Do not crush or chew delayed-release products. Acid suppression can reduce absorption of nutrients and drugs that require gastric acidity.

Depletions

What it depletes.

Nutrients this medication can lower over time, and what to replace.

Magnesium

Significant

Long-term PPI therapy can impair intestinal magnesium absorption and cause clinically significant hypomagnesemia.

Replace Magnesium GlycinateMonitor Serum magnesiumOnset Usually after months to years, but earlier in susceptible patients

Vitamin B12

Moderate

Reduced gastric acid can impair release of protein-bound vitamin B12 from food.

Replace Vitamin B12Monitor Serum vitamin B12 with methylmalonic acid when neededOnset Typically after 2 or more years of continuous acid suppression

Iron

Moderate

Reduced gastric acidity can lower solubilization and absorption of non-heme iron.

Replace IronMonitor Ferritin, transferrin saturation, hemoglobinOnset Months to years, especially with low stores or ongoing blood loss

Calcium

Mild

Acid suppression may reduce absorption of some calcium salts and is associated with fracture risk during high-dose or long-term therapy.

Replace CalciumMonitor 25-hydroxyvitamin D, calcium intake assessment, bone density when indicatedOnset Months to years
Safety

Full safety detail.

Side effects

  • Headache
  • Diarrhea
  • Nausea
  • Abdominal pain
  • Flatulence
  • Clostridioides difficile-associated diarrhea
  • Hypomagnesemia with prolonged therapy
  • Vitamin B12 deficiency with long-term use
  • Acute interstitial nephritis
  • Cutaneous or systemic lupus erythematosus
  • Fundic gland polyps
  • Bone fracture risk with high-dose or long-term therapy

Contraindications

  • Known hypersensitivity to rabeprazole, substituted benzimidazoles, or formulation components4
  • Do not use with rilpivirine-containing products due to reduced antiviral exposure4
  • Use caution with unexplained weight loss, gastrointestinal bleeding, dysphagia, or suspected malignancy
  • Use the lowest effective duration when long-term therapy is not clearly indicated1,3
Interactions

Interaction records.

ModerateCaution

Vitamin B12

Rabeprazole can reduce absorption of food-bound vitamin B12 during prolonged therapy.

Recommendation: Monitor B12 status during long-term therapy or symptoms of neuropathy, anemia, or cognitive change; oral crystalline or sublingual B12 may still be effective.

InfoSynergy

Magnesium Glycinate

Magnesium supplementation may help correct low magnesium during PPI therapy, but severe PPI-associated hypomagnesemia can require stopping the PPI.

Recommendation: Check serum magnesium if symptoms or risk factors are present; do not rely on supplements alone for severe hypomagnesemia.

ModerateCaution

Iron

Rabeprazole can reduce non-heme iron absorption, making oral iron response less reliable.

Recommendation: Monitor ferritin and hemoglobin if iron is prescribed; consider timing, vitamin C coadministration, or alternative iron strategies when response is poor.

ModerateTiming Sensitive

Calcium

Acid suppression may reduce absorption of calcium carbonate more than calcium citrate and long-term PPI therapy is associated with fracture risk.

Recommendation: Use adequate calcium and vitamin D intake; calcium citrate may be preferred if acid suppression is continuous.

InfoSynergy

Vitamin C

Vitamin C can improve non-heme iron absorption and may partly offset reduced iron solubility during acid suppression.

Recommendation: Pair vitamin C with oral iron if tolerated, while monitoring objective iron response.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

1
  • 1Proton pump inhibitor-associated hypomagnesemia: a systematic review and meta-analysisNeeds reviewNo linkPark CH et al. · PLOS One · 2014

    Observational evidence supports an association between PPI exposure and low magnesium, especially with concurrent diuretics or long duration.

Reviews & position papers

1
  • 2Effect of omeprazole on iron absorptionNeeds reviewNo linkHutchinson C et al. · Gut · 2007

    Acid suppression can reduce non-heme iron absorption, with clinical relevance in iron deficiency or marginal intake.

Observational studies

1
  • 3Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiencyNeeds reviewNo linkLam JR et al. · JAMA · 2013

    Large case-control data linked longer acid-suppressive therapy with higher odds of vitamin B12 deficiency.

Reference material

1
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Rabeprazole in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.